Arkolith/Insider Trading/UNCY/Form 4

Jermasek Douglas

EVP of Corporate StrategyUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4 · filed Jul 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Option exercise(M)105K——175K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2023Option exercise(M)50$1000.00$50K0
Jul 11, 2023Option exercise(M)115K——115K
Jul 11, 2023Option exercise(M)79K——79K
Jul 11, 2023Option exercise(M)72K——72K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-056875) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML